ニュース/Reuters/Janux Therapeutics Announces Positive Initial Phase 1 Data For JANX011 In Healthy Volunteers, Supporting Planned Development In Patient…Janux Therapeutics Announces Positive Initial Phase 1 Data For JANX011 In Healthy Volunteers, Supporting Planned Development In Patients With Autoimmune Disease記事の全文を読むReutersをはじめ、TradingViewで提供されるあらゆるニュースソースの記事に無制限でアクセスできます。続きを読む
